{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:23:43Z","timestamp":1787801023984,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.7759\/cureus.59538","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T19:12:25Z","timestamp":1714677145000},"source":"Crossref","is-referenced-by-count":5,"title":["Myasthenia Gravis Triggered by a COVID-19 Infection: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Alexandra","family":"Minc\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos I","family":"Minc\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia L","family":"Calinoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Gheorghi\u021b\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu C","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Rusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M","family":"Cristea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana G","family":"Minc\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser L","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021, 10:2235. 10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough DM","year":"1973","unstructured":"Fambrough DM, Drachman DB, Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science. 1973, 182:293-5. 10.1126\/science.182.4109.293","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville J","year":"2004","unstructured":"McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004, 55:580-4. 10.1002\/ana.20061","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch W","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001, 7:365-8. 10.1038\/85520","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner A","year":"2012","unstructured":"Pevzner A, Schoser B, Peters K, et al.. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol. 2012, 259:427-35. 10.1007\/s00415-011-6194-7","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus NE","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015, 14:1023-36. 10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips LH 2nd","year":"2003","unstructured":"Phillips LH 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003, 998:407-12. 10.1196\/annals.1254.053","journal-title":"Ann N Y Acad Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1375\/183242706778025062","article-title":"Familial risks for diseases of myoneural junction and muscle in siblings based on hospitalizations and deaths in sweden","volume":"9","author":"Hemminki K","year":"2006","unstructured":"Hemminki K, Li X, Sundquist K. Familial risks for diseases of myoneural junction and muscle in siblings based on hospitalizations and deaths in sweden. Twin Res Hum Genet. 2006, 9:573-9. 10.1375\/183242706778025062","journal-title":"Twin Res Hum Genet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman DB","year":"1994","unstructured":"Drachman DB. Myasthenia gravis. N Engl J Med. 1994, 330:1797-810. 10.1056\/NEJM199406233302507","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00239-4","article-title":"Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations","volume":"11","author":"Parotto M","year":"2023","unstructured":"Parotto M, Gy\u00f6ngy\u00f6si M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, Herridge MS. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023, 11:739-54. 10.1016\/S2213-2600(23)00239-4","journal-title":"Lancet Respir Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus NE","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJ. Myasthenia gravis. Nat Rev Dis Primers. 2019, 5:30. 10.1038\/s41572-019-0079-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki A 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000, 55:16-23. 10.1212\/wnl.55.1.16","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.010","article-title":"Diagnosis of myasthenia gravis","volume":"36","author":"Pasnoor M","year":"2018","unstructured":"Pasnoor M, Dimachkie MM, Farmakidis C, Barohn RJ. Diagnosis of myasthenia gravis. Neurol Clin. 2018, 36:261-74. 10.1016\/j.ncl.2018.01.010","journal-title":"Neurol Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20731","article-title":"Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?","volume":"8","author":"Cavalcante P","year":"2017","unstructured":"Cavalcante P, Marcuzzo S, Franzi S, et al.. Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?. Oncotarget. 2017, 8:95432-49. 10.18632\/oncotarget.20731","journal-title":"Oncotarget"},{"key":"ref15","article-title":"Adams and Victor\u2019s Principles of Neurology","author":"Ropper AH","year":"2014","unstructured":"Ropper AH, Samuels MA, Klein JP. Adams and Victor\u2019s Principles of Neurology. McGraw Hill, New York, NY; 2014."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.52586\/S555","article-title":"Review article on COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"13","author":"Patnaik UJ","year":"2021","unstructured":"Patnaik UJ. Review article on COVID-19 and Guillain-Barr\u00e9 syndrome. Front Biosci (Schol Ed). 2021, 13:97-104. 10.52586\/S555","journal-title":"Front Biosci (Schol Ed)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_33_22","article-title":"New-onset ocular myasthenia gravis following SARS-CoV-2 infection","volume":"16","author":"Banerjee P","year":"2023","unstructured":"Banerjee P, Hassan H, Alam MS. New-onset ocular myasthenia gravis following SARS-CoV-2 infection. Oman J Ophthalmol. 2023, 16:187-8. 10.4103\/ojo.ojo_33_22","journal-title":"Oman J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious onset of myasthenia gravis in a COVID-19 patient","volume":"11","author":"Huber M","year":"2020","unstructured":"Huber M, Rogozinski S, Puppe W, Framme C, H\u00f6glinger G, Hufendiek K, Wegner F. Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol. 2020, 11:576153. 10.3389\/fneur.2020.576153","journal-title":"Front Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini A","year":"2021","unstructured":"Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021, 28:3537-9. 10.1111\/ene.14721","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava S","year":"2021","unstructured":"Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2021, 268:2690-6. 10.1007\/s00415-020-10263-1","journal-title":"J Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo DA","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020, 173:1027-8. 10.7326\/L20-0845","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.09.001","article-title":"SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature","volume":"32","author":"Ramdas S","year":"2022","unstructured":"Ramdas S, Hum RM, Price A, et al.. SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature. Neuromuscul Disord. 2022, 32:785-9. 10.1016\/j.nmd.2022.09.001","journal-title":"Neuromuscul Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7326\/L20-1298","article-title":"MuSK antibody-associated myasthenia gravis with SARS-CoV-2 infection: a case report","volume":"174","author":"Muhammed L","year":"2021","unstructured":"Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody-associated myasthenia gravis with SARS-CoV-2 infection: a case report. Ann Intern Med. 2021, 174:872-3. 10.7326\/L20-1298","journal-title":"Ann Intern Med"},{"key":"ref24","article-title":"Coincidental onset of ocular myasthenia gravis following ChAdOx1 n-CoV-19 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"24","author":"Galassi G","year":"2022","unstructured":"Galassi G, Rispoli V, Iori E, Ariatti A, Marchioni A. Coincidental onset of ocular myasthenia gravis following ChAdOx1 n-CoV-19 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Isr Med Assoc J. 2022, 24:9-10.","journal-title":"Isr Med Assoc J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06284-5","article-title":"New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series","volume":"43","author":"Fanella G","year":"2022","unstructured":"Fanella G, Baiata C, Candeloro E, et al.. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series. Neurol Sci. 2022, 43:5799-802. 10.1007\/s10072-022-06284-5","journal-title":"Neurol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2789","article-title":"COVID-19 and myasthenia gravis: a review of neurological implications of the SARS-COV-2","volume":"12","author":"Shah SM","year":"2022","unstructured":"Shah SM, Yasmin F, Memon RS, et al.. COVID-19 and myasthenia gravis: a review of neurological implications of the SARS-COV-2. Brain Behav. 2022, 12:e2789. 10.1002\/brb3.2789","journal-title":"Brain Behav"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-012-8303-9","article-title":"The influence of pregnancy on systemic immunity","volume":"54","author":"Pazos M","year":"2012","unstructured":"Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res. 2012, 54:254-61. 10.1007\/s12026-012-8303-9","journal-title":"Immunol Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003339","article-title":"Increased risk for clinical onset of myasthenia gravis during the postpartum period","volume":"87","author":"Boldingh MI","year":"2016","unstructured":"Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekj\u00e6r H, Verschuuren JJ, Tallaksen CM. Increased risk for clinical onset of myasthenia gravis during the postpartum period. Neurology. 2016, 87:2139-45. 10.1212\/WNL.0000000000003339","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/250588-myasthenia-gravis-triggered-by-a-covid-19-infection-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T19:12:29Z","timestamp":1714677149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/250588-myasthenia-gravis-triggered-by-a-covid-19-infection-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.59538","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}